Guardant Health (NASDAQ:GH) 报告季度每股亏损$(0.62)，这比分析师一致预期的每股亏损$(0.74)高出16.22%。与去年同期每股亏损$(0.64)相比增长3.13%。公司报告季度销售额为$201.814M，比分析师一致预期的$192.141M超出5.03%。与去年同期销售额$155.054M相比增长30.16%。
以上内容来自Benzinga Earnings专栏，原文如下：
Guardant Health (NASDAQ:GH) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(0.74) by 16.22 percent. This is a 3.13 percent increase over losses of $(0.64) per share from the same period last year. The company reported quarterly sales of $201.814 million which beat the analyst consensus estimate of $192.141 million by 5.03 percent. This is a 30.16 percent increase over sales of $155.054 million the same period last year.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。